Opportunity Information: Apply for CDC RFA DP13 1310
Apply for CDC RFA DP13 1310
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Collaboration for Improving and Promoting Standardized Cancer Staging Using the Collaborative Stage Data Collection System" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.068 Chronic Diseases Research, Control, and Prevention.
- This funding opportunity was created on Apr 29, 2013 and posted on Apr 29, 2013.
- Applicants must submit their applications by Jun 10, 2013 Dates Optional Letter of Intent Deadline Date May 13, 2013 500 p.m. U.S. Eastern Daylight Savings Time Application Deadline Date June 10, 2013, 1159 p.m. U.S. Eastern Standard Time, on www.grants.gov. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,100,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligibility Information Eligible Applicants American Indian/Alaska Native tribal governments (federally recognized or state recognized) American Indian/Alaska native tribally designated organizations Alaska Native health corporations Colleges Community based organizations Faith based organizations For profit organizations (other than small business) Hospitals Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Political subdivisions of States (in consultation with States) Research institutions (that will perform activities deemed as non research) Small, minority, and women owned businesses State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . Tribal epidemiology centers Universities Urban Indian health organizations 2. Special Eligibility Requirements Applicants must provide documentation of prior experience in developing, monitoring, updating, and maintaining the Collaborative Stage Data Collection System (CS). Applicant must provide documentation of prior experience in providing overall management and coordination of CS activities for a nationwide organizational infrastructure, at a minimum of 25 states/territories. Applicant must provide documentation demonstrating the capacity to partner with and bring together organizations, agencies, and stakeholders from across the country for a national CS governance committee comprised of all cancer surveillance standards setting agencies and others with expert level knowledge of current and past AJCC TNM and Summary Stage cancer staging systems and of hospital and central cancer registry operations and standards.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Collaboration for Improving and Promoting Standardized Cancer Staging Using the Collaborative Stage Data Collection System," was a CDC discretionary funding announcement (Funding Opportunity Number CDC RFA DP13-1310) offered as a cooperative agreement. The overall goal was to strengthen how cancer stage information is collected and standardized for cancer surveillance by emphasizing coordination across the major agencies and organizations that set cancer staging standards and rely on staging data. In practical terms, CDC was looking to fund a single national partner that could help keep cancer staging consistent, usable, and up to date across the U.S. cancer surveillance infrastructure, while also reducing unnecessary complexity in the staging system so it remains feasible for hospitals and cancer registries to implement.
The announcement focuses on three connected purposes. First, it aimed to improve standardized staging for cancer surveillance, meaning better alignment and consistency in how stage at diagnosis is captured and reported so population-based cancer data can be compared across jurisdictions and over time. Second, it sought to support and simplify the evaluation, maintenance, and updating of cancer staging applications, recognizing that staging rules and schemas evolve (including linkages to staging frameworks such as AJCC TNM and Summary Stage) and that the tools used by registries and hospitals need structured governance and ongoing technical work to stay current. Third, it encouraged enhancements that reduce system complexity, which is important because staging systems can become burdensome when they require extensive manual interpretation or frequent rework by registrars and registry programs; simplifying attributes and processes can improve data quality and timeliness.
The funding instrument was a cooperative agreement, which generally implies substantial involvement by CDC in the funded work rather than a hands-off grant. The program was listed under CFDA 93.068 (Chronic Diseases Research, Control, and Prevention). CDC anticipated making one award, with an estimated total funding level of $2,100,000. The listing did not specify an award ceiling or floor, and there was no cost sharing or matching requirement.
Eligibility was broad in the general sense, including state and local governments and their bona fide agents (including U.S. territories and associated jurisdictions), tribal governments and tribal entities, universities and colleges, hospitals, nonprofit and for-profit organizations (other than small businesses), community and faith-based organizations, research institutions performing non-research activities, and small/minority/women-owned businesses. However, the practical eligibility was narrowed significantly by special requirements tied to the Collaborative Stage Data Collection System (CS). Applicants had to document prior experience developing, monitoring, updating, and maintaining CS, as well as prior experience managing and coordinating CS activities across a nationwide infrastructure reaching at least 25 states or territories. In addition, applicants needed to show capacity to convene and partner nationally by forming and supporting a governance committee that includes the cancer surveillance standards-setting agencies and other stakeholders with expert-level knowledge of both current and historical AJCC TNM and Summary Stage staging systems, along with operational expertise in hospital and central cancer registry standards. Taken together, these requirements indicate CDC was seeking an organization already deeply embedded in CS operations and national staging governance, capable of coordinating multiple standards bodies and end users.
Key dates were posted in spring 2013. The FOA was posted on April 29, 2013, with an optional letter of intent due May 13, 2013 by 5:00 p.m. Eastern (daylight time noted), and the full application due June 10, 2013 at 11:59 p.m. Eastern via Grants.gov. The opportunity later archived on July 10, 2013. For technical access issues with the full announcement, CDC directed applicants to the Procurement and Grants Office Technical Information Management Section (TIMS) via phone (770-488-2700) or email (pgotim@cdc.gov).
In summary, this FOA funded one national coordinating partner to sustain and improve the Collaborative Stage Data Collection System as a standardized cancer staging solution for surveillance, with strong emphasis on cross-agency collaboration, structured national governance, continuous maintenance and updates, and deliberate efforts to streamline the system so it remains practical for widespread registry and hospital use.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Collaboration for Improving and Promoting Standardized Cancer Staging Using the Collaborative Stage Data Collection System."
Who offered this funding opportunity?
The opportunity was offered by CDC as a discretionary funding announcement.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA DP13-1310.
What type of funding mechanism was used?
The funding instrument was a cooperative agreement, which typically means CDC would have substantial involvement in the funded activities rather than operating as a hands-off funder.
What is the CFDA number associated with this opportunity?
The program was listed under CFDA 93.068 (Chronic Diseases Research, Control, and Prevention).
What was the overall goal of the announcement?
The overall goal was to strengthen how cancer stage information is collected and standardized for cancer surveillance by emphasizing coordination across the major agencies and organizations that set cancer staging standards and rely on staging data.
What was CDC looking to fund in practical terms?
CDC was looking to fund a single national partner to help keep cancer staging consistent, usable, and up to date across the U.S. cancer surveillance infrastructure, while also reducing unnecessary complexity so the staging system remains feasible for hospitals and cancer registries to implement.
How many awards did CDC anticipate making?
CDC anticipated making one award.
What was the estimated total funding amount?
The estimated total funding level was $2,100,000.
Was an award ceiling or floor specified?
No. The listing did not specify an award ceiling or an award floor.
Was cost sharing or matching required?
No cost sharing or matching requirement was stated.
What cancer staging system was central to this opportunity?
The opportunity centered on the Collaborative Stage Data Collection System (CS).
What were the three main purposes described in the announcement?
The announcement described three connected purposes: (1) improving standardized staging for cancer surveillance (better alignment and consistency in stage-at-diagnosis capture and reporting), (2) supporting and simplifying the evaluation, maintenance, and updating of cancer staging applications as rules and schemas evolve (including linkages to AJCC TNM and Summary Stage), and (3) encouraging enhancements that reduce system complexity so implementation is more feasible for hospitals and registries and can improve data quality and timeliness.
What does "improve standardized staging for cancer surveillance" mean in this FOA?
It refers to improving alignment and consistency in how stage at diagnosis is captured and reported so population-based cancer data can be compared across jurisdictions and over time.
Why did the FOA emphasize ongoing maintenance and updating of staging applications?
Because staging rules and schemas evolve over time, and the tools used by registries and hospitals require structured governance and ongoing technical work to remain current, including their linkages to frameworks such as AJCC TNM and Summary Stage.
Why was reducing system complexity an explicit focus?
Staging systems can become burdensome when they require extensive manual interpretation or frequent rework by registrars and registry programs. Reducing unnecessary complexity and simplifying attributes and processes can support better data quality and timeliness.
Who was eligible to apply (general categories)?
Eligibility categories included state and local governments and their bona fide agents (including U.S. territories and associated jurisdictions), tribal governments and tribal entities, universities and colleges, hospitals, nonprofit and for-profit organizations (other than small businesses), community and faith-based organizations, research institutions performing non-research activities, and small/minority/women-owned businesses.
Did the announcement include special requirements that narrowed practical eligibility?
Yes. Although the general eligibility list was broad, applicants had to meet special requirements tied to the Collaborative Stage Data Collection System (CS), which significantly narrowed practical eligibility.
What prior experience with the Collaborative Stage Data Collection System (CS) was required?
Applicants had to document prior experience developing, monitoring, updating, and maintaining CS.
Was nationwide coordination experience required?
Yes. Applicants had to document prior experience managing and coordinating CS activities across a nationwide infrastructure reaching at least 25 states or territories.
Was a national governance capability required?
Yes. Applicants needed to show capacity to convene and partner nationally by forming and supporting a governance committee.
Who needed to be represented on the governance committee described in the FOA?
The governance committee was described as including cancer surveillance standards-setting agencies and other stakeholders with expert-level knowledge of both current and historical AJCC TNM and Summary Stage staging systems, along with operational expertise in hospital and central cancer registry standards.
What does the FOA imply about the type of organization CDC wanted to fund?
Taken together, the requirements indicate CDC was seeking an organization already deeply embedded in CS operations and national staging governance, capable of coordinating multiple standards bodies and end users.
When was the FOA posted?
The FOA was posted on April 29, 2013.
Was a letter of intent required?
A letter of intent was optional.
When was the optional letter of intent due?
The optional letter of intent was due May 13, 2013 by 5:00 p.m. Eastern (daylight time noted).
When was the full application due?
The full application was due June 10, 2013 at 11:59 p.m. Eastern via Grants.gov.
Where were applications submitted?
Applications were submitted via Grants.gov.
When was the opportunity archived?
The opportunity later archived on July 10, 2013.
Who could applicants contact for technical access issues with the full announcement?
For technical access issues, CDC directed applicants to the Procurement and Grants Office Technical Information Management Section (TIMS) by phone at 770-488-2700 or by email at pgotim@cdc.gov.
What was the central theme of the funded work?
The central theme was national collaboration and coordination to sustain and improve the Collaborative Stage Data Collection System as a standardized cancer staging solution for surveillance, with structured governance, continuous maintenance and updates, and deliberate streamlining to keep implementation practical for registries and hospitals.
Browse more opportunities from the same category: Health
Next opportunity: Colorado Dust on Snow Program
Previous opportunity: National Park Service Catalog and Make Archeological Dendrochronology Speciman Web
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP13 1310
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP13 1310) also looked into and applied for these:
| Funding Opportunity |
|---|
| Announcement of the Availability of Funds for Office of Research Integrity (ORI) Extramural Research Grants Apply for IR ORI 13 001 Funding Number: IR ORI 13 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
| Maternal and Child Health Measurement Research Network Apply for HRSA 13 259 Funding Number: HRSA 13 259 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Cancer Surveillance Data Standards and Best Practices Apply for CDC RFA DP13 1308 Funding Number: CDC RFA DP13 1308 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Strengthening the Nations Public Health System through a National Voluntary Accreditation Program for State, Tribal, Local and Territorial Health Departments Apply for CDC RFA OT13 1301 Funding Number: CDC RFA OT13 1301 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| International TNM and Capacity Building Apply for CDC RFA DP13 1309 Funding Number: CDC RFA DP13 1309 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $175,000 |
| Closing the Gap in Healthcare Disparities through Dissemination and Implementation of Patient Centered Outcomes Research (U18) Apply for RFA HS 13 010 Funding Number: RFA HS 13 010 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Effective Communication Programming for Increasing Utilization of Family Planning and Reproductive Health (FP/RH) Services in Jordan Apply for RFA 278 13 000003 Funding Number: RFA 278 13 000003 Agency: Jordan USAID Amman Category: Health Funding Amount: Case Dependent |
| National Organizations Support for State Oral Health Programs Apply for CDC RFA DP13 1313 Funding Number: CDC RFA DP13 1313 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Developing and Improving Institutional Animal Resources (G20) Apply for PAR 13 219 Funding Number: PAR 13 219 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Center of Excellence for Research on CAM (P01) Apply for PAR 13 220 Funding Number: PAR 13 220 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methodologies and Formative Work for Combination HIV Prevention Approaches (R01) Apply for RFA MH 14 180 Funding Number: RFA MH 14 180 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Methodologies and Formative Work for Combination HIV Prevention Approaches (R21) Apply for RFA MH 14 181 Funding Number: RFA MH 14 181 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Methodologies and Formative Work for Combination HIV Prevention Approaches (R34) Apply for RFA MH 14 182 Funding Number: RFA MH 14 182 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Biomonitoring of Great Lakes Populations Apply for CDC RFA TS13 1302 Funding Number: CDC RFA TS13 1302 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $470,000 |
| Enhancing the Environmental Health Workforce by Strengthening Environmental Health Academic Programs Apply for CDC RFA EH13 1304 Funding Number: CDC RFA EH13 1304 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| The Effects of Modulating Chronic Low Grade Inflammation on Geriatric Conditions Secondary Data and/or Biospecimen Analyses and Ancillary Studies in Ongoing or Completed Clinical Trials (R01) Apply for PA 13 221 Funding Number: PA 13 221 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sodium Reduction in Communities Apply for CDC RFA DP13 1301 Funding Number: CDC RFA DP13 1301 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Native Hawaiian Health Care Improvement Act Apply for HRSA 13 238 Funding Number: HRSA 13 238 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving state and local capacity to assess and manage risks associated with private wells and other small drinking water systems by using the Environmental Health Specialist Network (EHS Net) Apply for CDC RFA EH13 1301 Funding Number: CDC RFA EH13 1301 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $175,000 |
| Centers for Disease Control and Prevention Public Health Preparedness and Response Research to Aid Recovery from Hurricane Sandy Apply for RFA TP 13 001 Funding Number: RFA TP 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $608,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP13 1310", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.